Vascular Access Devices Market is expected to Surge at a Significant CAGR of 6.64% and is also contemplated to Reach Upto USD 6.13 Billion by 2026, Estimates DelveInsight

Global Vascular Access Devices Market was valued at USD 4.59 billion in 2021, growing at a CAGR of 6.64% during the forecast period from 2022 to 2027, to reach USD 6.75 billion by 2027. The demand for Vascular Access Devices is primarily motivated by the growing prevalence of chronic diseases like cancer, kidney failure, and heart diseases that requires the use of these devices. Some other factors like the rise in the number of chemotherapies, lifestyle diseases, and their rising occurrence in pediatric patients may drive the growth of the market.

Vascular Access Devices Overview
Vascular access devices are types of equipment that are inserted inside the body through a vein to enable the administration of fluids, blood products, medication, and other therapies to the bloodstream. These devices allow repeated and long-term access to the bloodstream for frequent or regular administration of drugs, like intravenous (IV) antibiotics. The vascular access tubes are made of silicone, latex, and other substances.

Download Sample Report- https://www.delveinsight.com/sample-request/vascular-access-device-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Recent Developmental Activities in the Vascular Access Devices Market:
• In August 2021, PuraCath Medical™, a venture-backed startup company focusing on the development of technologies to reduce infections in patients with intravascular catheters, announced that it has received 510(k) clearance for its FireFly™ Needleless Connector from the US Food and Drug Administration (FDA). The Firefly™ Needleless Connector is a sterile single patient use connector for needleless access to the IV line and IV catheter during IV therapy and can be used for direct injection, intermittent infusion, continuous infusion, or aspiration. This regulatory determination by the FDA gives PuraCath clearance to market the FireFly™ needleless connector in the US.
• In July 2021, Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, announced it has completed enrolment in its first-in-human study evaluating the company's Amplifi™ Vein Dilation System. The Amplifi System is designed to stimulate arm vein enlargement in hemodialysis patients using rapid, non-pulsatile venous blood flow. Novel vein dilation system aims to improve vascular access for hemodialysis patients.

Key Takes Away from the Vascular Access Devices Market Report Study
• Market size analysis for current market size (2021), and market forecast for 5 years (2022-2027)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Vascular Access Devices market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the Global Vascular Access Devices Market.
• Various opportunities are available for the other competitor in the Vascular Access Devices Market space.
• What are the top-performing segments in 2021? How these segments will perform in 2027?
• Which are the top-performing regions and countries in the current market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Vascular Access Devices market growth in the coming future?

Vascular Access Devices Market Dynamics
Vascular access devices are types of equipment that are inserted inside the body through a vein to enable the administration of fluids, blood products, medication, and other therapies to the bloodstream. These devices allow repeated and long-term access to the bloodstream for frequent or regular administration of drugs, like intravenous (IV) antibiotics. The vascular access tubes are made of silicone, latex, and other substances.

Vascular Access Devices Prevalence
These devices are used due to the high prevalence of end-stage renal disease (ESRD), leading to chronic kidney disease (CKD). According to the Centers for Disease Control and Prevention (CDC), as per the 2015-2018 National Health and Nutrition Examination Survey and the CKD Epidemiology Collaboration, more than 1 in 7, that is 15% of US adults or 37 million people, are estimated to have CKD. As per the National Kidney Foundation Inc., approximately 1 in 3 adults with diabetes and 1 in 5 adults with high blood pressure may have kidney disease. For patients undergoing dialysis treatment, this eventually leads to more and more usage of vascular access devices among patients.

Do you want to know about the market size? If yes, visit here- https://www.delveinsight.com/report-store/vascular-access-device-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Vascular Access Devices Market Segment Analysis
• Vascular Access Devices by Device Type (Central Vascular Access Devices-Peripherally Inserted Central Catheters, Non-Tunneled Catheters, Others, and Peripheral Vascular Access Devices- Peripheral Catheter, Midline Catheter (short) Devices, Others)
• Vascular Access Devices market by Route of Insertion (Intravenous, Subcutaneous),
• Vascular Access Devices market by End User (Hospitals, Ambulatory Surgical Centres, and Others),
• Vascular Access Devices market by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

North America is expected to dominate the overall Vascular Access Devices market during the forecast period
This domination is due to the growing demand for advanced technologies in vascular access devices, the rising need to treat chronic kidney disease in the region is driving the regional growth. Further, in the United States, the risk of being affected by a chronic disease is increasing dramatically due to the rising geriatric population. This situation is giving rise to a critical need for vascular access devices for the diagnosis, prevention, and treatment of chronic disease. Europe and Asia-Pacific region have the future potential growth for the Global Vascular Access Devices. This is due to the rising burden of chronic diseases in the European region countries and Asian countries also. In all countries, chronic illness rates have been increasing.

Vascular Access Devices Market Insight
Geographically, the Global Vascular Access Device market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. In terms of revenue share, North America tends to lead the global market in the present scenario and is expected that it will continue to remain superior during the forecast period. However, the domination exhibited by North America will be conspicuously challenged by the European market. This domination is attributed to the rising prevalence of cancer, the rise in the number of cases pertaining to end-stage renal diseases, and the increase in the prevalence of cardiovascular disorders.

Vascular Access Devices Market Drivers and Barriers
The Global Vascular Access Device market is expected to witness significant growth owing to several factors such as the rising cases of blood transfusions, rising demand of patients for central venous access during long periods of intravenous therapy, for instance, chemotherapy and antimicrobial therapy, demand for technologically advanced Vascular Access Devices and the rise in the number of lifestyle related disorders. In addition to these are aspects such as rise in the prevalence of chronic kidney disease, patients encounter reduced stress, pain when using Vascular Access Devices, and the discomfort that arises due to repetitive injection of needle syringe all lead to increasing the Vascular Access Device market growth.

Vascular Access Devices Market Companies
Some of the key market players operating in the Vascular Access Devices market include Cook Medical Inc., Becton, Dickinson, and Company, Teleflex Incorporated, Medtronic PLC, Zoll Medical Corporation, B Braun Melsungen AG, Prodimed, Amecath Medical Technologies, Terumo Medical Corporation, AngioDynamics, Edwards Lifesciences Corporation, C. R. Bard, Inc., Smiths Group PLC, Nipro Medical Corporation, and others.

Request Sample Report- https://www.delveinsight.com/sample-request/vascular-access-device-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Vascular Access Devices Market Report Introduction
2. Vascular Access Devices Market Executive summary
3. Regulatory and Patent Analysis
4. Vascular Access Devices Market Key factors analysis
5. Vascular Access Devices Porter's Five Forces Analysis
5.5. Competitive Rivalry
6. COVID-19 Impact Analysis on Vascular Access Devices Market
7. Vascular Access Devices Market layout
8. Vascular Access Devices Global Company Share Analysis - Key 3-5 Companies
9. Vascular Access Devices Company and Product Profiles
10. Project Approach
11. KOL Views
12. DelveInsight Capabilities
13. Disclaimer
14. About DelveInsight

Do you have any query related to report? If yes, visit here- https://www.delveinsight.com/report-store/vascular-access-device-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Contact Us
Yash
info@delveinsight.com

About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

This release was published on openPR.